Showing results (1021-1030 of 15,690) with videos related to

Sort By:
Pageof 1,569
Oncology Letters|June 19, 2024
Real‑world retrospective study of early‑stage prostate cancer at a Portuguese Comprehensive Cancer Centre: The PEarlC studyIsaac Braga, Salomé Gonçalves-Monteiro, Rita Calisto, et al.
Oncology Letters|January 23, 2023
Target concentration achievement for efficacy and safety of patients with osteosarcoma treated with high-dose methotrexate based on individual pharmacokinetics: A retrospective studyAyumu Nagamine, Takuya Araki, Hideaki Yashima, et al.
Oncology Letters|January 23, 2023
Jumonji AT-rich interactive domain 1B promotes the growth of pancreatic tumors via the phosphatase and tensin homolog/protein kinase B signaling pathwayXudong Shen, Guilian Cheng, Liming Xu, et al.
Oncology Letters|January 23, 2023
Long non-coding RNA PVT1 promotes the proliferation, migration and EMT process of ovarian cancer cells by regulating CTGFLingling Dong, Huan Wang, Yun Gao, et al.
Oncology Letters|January 23, 2023
Clinicopathological and prognostic value of long non-coding RNA CCAT1 expression in patients with digestive system cancerYue Yu, Zhihua Xu, Hao Ni, et al.
Oncology Letters|January 16, 2023
Molecular targeted therapy: A new avenue in glioblastoma treatmentOula El Atat, Rayan Naser, Maya Abdelkhalek, et al.
Oncology Letters|January 16, 2023
Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasiaXiaobo Zhang, Xiaoya Zhao, Chen Wang, et al.
Oncology Letters|January 16, 2023
Side effects of tyrosine kinase inhibitors therapy in patients with non-small cell lung cancer and associations with EGFR polymorphisms: A systematic review and meta-analysisJasmina Obradovic, Jovana Todosijevic, Vladimir Jurisic
Oncology Letters|January 16, 2023
BTK inhibitor combined with anti-PD-1 monoclonal antibody for the treatment of CD20-negative primary central nervous system lymphoma: A case reportLan Feng, Xiaohui Gao, Zhiyun Jiao, et al.
Oncology Letters|January 16, 2023
Identification and validation of DPY30 as a prognostic biomarker and tumor immune microenvironment infiltration characterization in esophageal cancerPei-Yuan Mei, Han Xiao, Qiang Guo, et al.
Pageof 1,569